Listed
Stock Code: 389030
| Company Name | 지니너스 주식회사 |
| English Name | GENINUS Inc. |
| Business Reg. No. | 2038801251 |
| CEO | 박웅양 |
| Address | 서울특별시 송파구 정의로 70 4층, 5층(문정동, 케이디유타워) |
| Industry | 의학 및 약학 연구개발업 |
| Industry Code | 70113 |
| Established | 20180420 |
| Phone | 02-6949-6570 |
| Website | kr-geninus.com |
| Regular Employees | 63persons |
| Corp. Reg. No. | 1101116728781 |
Venture Certified
| 벤처투자유형 | 2019-04-11 ~ 2021-04-10 | 20190300309 | 2019-04-11 |
| 벤처투자유형 | 2021-04-11 ~ 2024-04-10 | 20210520010002 | 2019-04-11 |
| 벤처투자유형 | 2024-04-11 ~ 2027-04-10 | 20240513010011 | 2019-04-11 |
Revenue CAGR -7.4%
| Item | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Revenue | 65B | 70B | 101B | 81B |
| Operating Profit | -123B | -101B | -97B | -76B |
| Net Profit | -123B | -97B | -94B | -90B |
| Total Assets | 331B | 405B | 458B | 581B |
| Total Liabilities | 109B | 60B | 26B | 62B |
| Total Equity | 222B | 345B | 433B | 519B |
Operating Loss: Op. profit -123B
4 Consecutive Years of Net Loss
Debt Ratio Surge (+31pp YoY)
▼ 23.1%
▼ 34.3%
▼ 70.4%
▲ 314.8%
▼ 146.6%
| Name | Position | Role | Comp. (M KRW) |
|---|---|---|---|
| 박웅양 | 사내이사 | 대표이사 | - |
| 신성철 | 미등기 | AT센터장 | - |
| 김관수 | 미등기 | 재무이사 | - |
| 한정규 | 사외이사 | 사외이사 | - |
| 송정호 | 감사 | 감사 | - |
| 이상혁 | 사외이사 | 사외이사 | - |
| 오은설 | 미등기 | BI센터장 | - |
| 윤석환 | 미등기 | AI센터장 | - |
| 박종면 | 미등기 | 연구개발본부장 | - |
| 황정아 | 미등기 | 유전체분석센터장 | - |
| 장세훈 | 미등기 | 사업운영본부장 | - |
| Shareholder | Ownership (%) | Shares Held |
|---|---|---|
| - | ||
| - | ||
| - | ||
| - |
| NPS Subscribers | 54persons |
| CEO | 박웅양 |
| Est. Avg. Annual Salary | 5,21810K (43510K/mo) |
| Hired (12 mo) | +1persons |
| Left (12 mo) | -0persons |
| Net Change (12 mo) | +1persons |
| NPS Join Date | 2018-06-01 |
No Data – Contact
No procurement record or data not yet available| Tax Type | 부가가치세 일반과세자 |
| Status | Cert. flags confirmed (details update after further collection) |
2 Additional Data Sources
{
"address": "서울특별시 송파구",
"ceo_name": "박웅양",
"certificate": [
{
"cert_number": "20190300309",
"changes": "",
"disclosure_date": "2019-04-11",
"first_cert_date": "2019-04-11",
"no": "1",
"type": "벤처투자유형",
"valid_period": "2019-04-11 ~ 2021-04-10"
},
{
"cert_number": "20210520010002",
"changes": "",
"disclosure_date": "2021-05-20",
"first_cert_date": "2019-04-11",
"no": "2",
"type": "벤처투자유형",
"valid_period": "2021-04-11 ~ 2024-04-10"
},
{
"cert_number": "20240513010011",
"changes": "",
"disclosure_date": "2024-05-13",
"first_cert_date": "2019-04-11",
"no": "3",
"type": "벤처투자유형",
"valid_period": "2024-04-11 ~ 2027-04-10"
}
],
"company_name": "지니너스 주식회사",
"financials": {
"2022": {
"capital_stock": 16303973000,
"cost_of_sales": 9234213000,
"current_assets": 36553399000,
"current_liabilities": 2306162000,
"gross_profit": 849175000,
"net_income": -9384985000,
"net_income_bs": -9384985000,
"non_current_assets": 9276372000,
"non_current_liabilities": 253456000,
"non_operating_expenses": 33645000,
"non_operating_income": 324715000,
"operating_profit": -9676055000,
"revenue": 10083387000,
"sga_expenses": 10525230000,
"total_assets": 45829771000,
"total_equity": 43270153000,
"total_liabilities": 2559618000
}
},
"industry": "의학 및 약학 연구개발업",
"investment": [
{
"amount": "5,000,000,000",
"changes": "5,000,000,000",
"date": "2020-07-24"
},
{
"amount": "5,000,000,000",
"changes": "5,000,000,000",
"date": "2020-07-24"
},
{
"amount": "7,578,491,017",
"changes": "7,578,491,017",
"date": "2020-07-24"
},
{
"amount": "7,000,000,000",
"changes": "7,000,000,000",
"date": "2019-03-04"
},
{
"amount": "999,972,000",
"changes": "999,972,000",
"date": "2018-12-31"
},
{
"amount": "999,000,000",
"changes": "999,000,000",
"date": "2018-12-28"
},
{
"amount": "454,016,100",
"changes": "454,016,100",
"date": "2018-11-30"
}
],
"phone": "02-6949-****",
"source": "pg_migration"
}{
"address": "서울특별시 송파구 정의로",
"brno": "203880****",
"cappedWarning": false,
"companyName": "지니너스주식회사(GENINUSInc.)",
"estimatedAvgAnnualSalary": 52176888,
"estimatedAvgMonthlySalary": 4348074,
"fetchedAt": "2026-03-05T14:44:25.885Z",
"industryCode": "730000",
"industryName": "기타 인문 및 사회과학 연구개발업",
"joinDate": "20180601",
"last12MonthsHired": 1,
"last12MonthsLeft": 0,
"last12MonthsNetChange": 1,
"leaveDate": null,
"monthlyPensionAmount": 22305620,
"monthlyTrend": [
{
"lostSubscribers": 0,
"newSubscribers": 1,
"yearMonth": null
}
],
"npsRateUsed": 0.095,
"npsUpperCap": 6370000,
"seq": "6494330",
"status": "1",
"styleCode": "1",
"subscriberCount": 54,
"turnoverMonths": 1
}Data Quality: 95/10 | Primary Source: DART | Section Coverage: 8/8
| Section | Source: | Status |
|---|---|---|
| Basic Info | DART | Collected |
| Financial Statements | DART | Collected |
| Investment Metrics | DART | Collected |
| Officers | DART | Collected |
| Employment | DART | Collected |
| Certifications | Public Data | Collected |
| Patents | KIPRIS | Collected |
| Procurement | G2B Procurement | Collected |
| API | Collected | Status |
|---|---|---|
| Venture System Detail | 2026-03-05 | Collected |
| nps | 2026-03-05 | Collected |
| DART Financial | 2026-02-27 | Collected |
| G2B Procurement | 2026-02-25 | Collected |
| KIPRIS Patents | 2026-02-25 | Collected |
| Employment Insurance | 2026-02-25 | Collected |
| HomeTax Business | 2026-02-25 | Collected |
| Cert. Info | 2026-02-25 | Collected |